TFN NEWS BRIEFING: Pharmaceuticals and chemicals highlights to 09:10 BST |
|
|
|
Published
:
Wed, 25 Apr 2007 09:27
|
2007-04-25 08:00:59Solvay heart flutter drug filed tedisamil for FDA, EU approvalBRUSSELS (Thomson Financial) - Pharmaceuticals and chemicals group Solvay SAsays its intravenous tedisamil drug against abnormal rhythm of the smaller heartchambers has been filed for approval by the US Food and Drug Administration(FDA) as well as by European Union countries.2007-04-25 07:24:55Air Liquide Q1 sales 2.791 bln eur, up 0.6 pct; up 5.2 pct comparablePARIS (Thomson Financial) - Air Liquide said first quarter sales were 2.791bln eur, up 0.6 pct from a year earlier and up 5.2 pct on a comparable basis,with a strong rise in Asia as the key factor in the comparable growth.2007-04-25 07:07:57Siemens eyeing ex-Volkswagen executive Bernhard as next CEO - reportFRANKFURT (Thomson Financial) - Siemens AG's supervisory board is eyeingWolfgang Bernhard, former Chrysler and Volkswagen AG executive, as a possiblecandidate to replace chief executive Klaus Kleinfeld, Sueddeutsche Zeitungreprted, citing sources.2007-04-25 07:07:55Air Liquide Q1 sales 2.791 bln eur, up 0.6 pct; up 5.2 pct on comparable basisPARIS (Thomson Financial) - Air Liquide said first quarter sales were 2.791bln eur, up 0.6 pct from a year earlier and up 5.2 pct on a comparable basis,with a strong rise in Asia as the key factor in the comparable growth.2007-04-25 04:06:55Business HighlightsSAN JOSE, Calif. (AP) - The Securities and Exchange Commission filed civilcharges Tuesday against two former Apple Inc. officers over their alleged rolesin backdating stock options. One of them immediately settled the case and castsome blame on Apple CEO Steve Jobs.
|
|
|
|
|
|
Print this Story
Akzo Nobel ratings unchanged on planned biosciences sale, says S&P 